Figure 1.
Figure 1. Outcomes after transplantation using a targeted BU/CY regimen. Estimates of survival, DFS, and relapse at 3 years after transplantation are 86%, 78%, and 8%, respectively.

Outcomes after transplantation using a targeted BU/CY regimen. Estimates of survival, DFS, and relapse at 3 years after transplantation are 86%, 78%, and 8%, respectively.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal